A detailed history of Centiva Capital, LP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Centiva Capital, LP holds 5,923 shares of DGX stock, worth $811,984. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,923
Previous 5,000 18.46%
Holding current value
$811,984
Previous $665,000 21.8%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $116,214 - $133,225
923 Added 18.46%
5,923 $810,000
Q1 2024

May 15, 2024

SELL
$123.78 - $142.11 $793,306 - $910,782
-6,409 Reduced 56.17%
5,000 $665,000
Q4 2023

Feb 14, 2024

BUY
$120.62 - $141.12 $600,205 - $702,213
4,976 Added 77.35%
11,409 $1.57 Million
Q3 2023

Nov 14, 2023

BUY
$121.86 - $144.92 $145,378 - $172,889
1,193 Added 22.77%
6,433 $783,000
Q2 2023

Aug 14, 2023

BUY
$130.56 - $146.84 $396,771 - $446,246
3,039 Added 138.07%
5,240 $736,000
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $430,103 - $509,335
-3,270 Reduced 59.77%
2,201 $311,000
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $674,629 - $860,369
5,471 New
5,471 $855,000
Q4 2021

Feb 14, 2022

SELL
$140.36 - $173.01 $746,294 - $919,894
-5,317 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $706,895 - $840,086
5,317 New
5,317 $775,000
Q4 2020

Feb 16, 2021

SELL
$112.7 - $128.05 $198,577 - $225,624
-1,762 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $188,622 - $229,077
1,762 New
1,762 $202,000
Q1 2020

May 15, 2020

SELL
$75.14 - $115.68 $34,188 - $52,634
-455 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $37,107 - $39,956
370 Added 435.29%
455 $49,000
Q3 2019

Nov 13, 2019

BUY
$97.85 - $107.42 $8,317 - $9,130
85 New
85 $9,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.